As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...